Core Laboratories price target raised to $22 from $18 at Stifel

Stifel raised the firm’s price target on Core Laboratories to $22 from $18 and keeps a Hold rating on the shares. Core Labs delivered in-line Q2 operating income and Q3 operating income guidance bracketed the consensus, although the U.S. land outlook remains soft, says the analyst, who is lowering 2024-25 estimates and bumping up the firm’s price target on a roll-forward in valuation.